StartupWiki is a community-driven AI-powered research directory of global startup ventures. Explore in-depth profiles of AI, Biotech, CleanTech, FinTech, Cybersecurity, and other deep-tech startups with funding data, financial metrics, competitive analysis, and team insights.
Browse categories: AI & Machine Learning, FinTech, Biotech, Cybersecurity, CleanTech, Quantum Computing, and more.
Browse all startups A-Z for the complete directory.
Read our blog for startup insights and deep dives.
The AI-driven precision medicine company turning clinical and molecular data into actionable care
HQ: Chicago, IL, United States | Founded: 2015 | Employees: ~3,000 (2025, est.) | Stage: Public (Nasdaq: TEM); ~$1.43B revenue (2025) | Website: https://www.tempus.com
Tempus AI was founded by Eric Lefkofsky (co-founder of Groupon) in August 2015, after his wife's breast cancer diagnosis exposed the gap between available molecular data and how it's actually used in care. His thesis: amass the world's largest library of clinical and molecular data and apply AI to make that data actionable for doctors and patients. The company started with cancer (genomic testing, next-generation sequencing) and expanded across oncology, cardiology, radiology, and into AI algorithms and data licensing.\n\nThe business model layers three things: (1) diagnostics/testing services for labs and hospitals (the volume engine), (2) AI algorithms and software (Tempus One, the clinical-AI assistant; Tempus+ products), and (3) data licensing/insights to pharma and life-sciences partn
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki